UNBS5162, a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers.
Mijatovic T, Mahieu T, Bruyère C, De Nève N, Dewelle J, Simon G, Dehoux MJ, van der Aar E, Haibe-Kains B, Bontempi G, Decaestecker C, Van Quaquebeke E, Darro F, Kiss R.
Mijatovic T, et al.
Neoplasia. 2008 Jun;10(6):573-86. doi: 10.1593/neo.08290.
Neoplasia. 2008.
PMID: 18516294
Free PMC article.